We are delighted to announce the winning paper of the Highly Cited Paper Award 2024 for Exploration of Drug Science (EDS). This recognition celebrates the contributions of authors whose work has advanced the journal's academic influence. Our sincere gratitude goes to authors for their invaluable efforts in enriching the journal’s growth.   

Criteria for selection and award:
– Articles published in 2023-2024
– Both regular and special issue articles are considered
– Citations are counted according to Web of Science (WOS) in 2024;
– Prize for the author team: 300-1,000 USD, certificate of "Highly Cited Paper Award"
– Prize for the corresponding Guest Editor(s): 100-300 USD.
– A full APC waiver once, allowing to publish one article free of charge after February 1, 2028. 

Winning Paper:

★ Approved antibacterial drugs in the last 10 years: from the bench to the clinic
Authors: Miguel García-Castro*, Francisco Sarabia, Amelia Díaz-Morilla, Juan Manuel López-Romero
Special Issue: Exploring Potential Drugs from Natural Products

Congratulations to the award-wining team for their impactful contribution!

In the following year, EDS will continue to set "Highly Cited Paper Award" to honor impactful works and their authors. We warmly invite more researchers worldwide to participate in and contribute to the journal. Looking forward to seeing you being the next proud winner!